Why GLP-1 weight loss drugs are catching investor attention
SB Talks · Stanford Brown
November 8, 202317m 14s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This week Stanford Brown CEO Vincent O'Neill meets once again with CIO Nick Ryder to discuss:
- The RBA's widely anticipated rate hike and where to from here?
- Driving factors behind Australia's higher-than-expected inflation numbers
- Whether geopolitical risks impact portfolio positioning?
- The potential for GLP-1 "wonder drugs" to impact different companies such as Resmed and CSL
Music provided by: Autumn Trumpet Background Corporate by LesFM | https://lesfm.net/ Music promoted by https://www.chosic.com/free-music/all/ Creative Commons CC BY 3.0 https://creativecommons.org/licenses/by/3.0/